Ischemic memory imaging in nonhuman primates with echocardiographic molecular imaging of selectin expression.
BACKGROUND
Selectins are adhesion molecules that are expressed by the vascular endothelium upon activation and may be an imaging target for detecting myocardial ischemia long after resolution. The aim of this study was to test the hypothesis that molecular imaging of selectins with myocardial contrast echocardiographic (MCE) molecular imaging could be used to detect recent brief ischemia in closed-chest nonhuman primates.


METHODS
Myocardial ischemia was produced in anesthetized adult rhesus macaques (n = 6) by percutaneous balloon catheter occlusion of the left anterior descending or circumflex coronary artery for 5 to 10 min. Three separate macaques served as nonischemic controls. MCE perfusion imaging was performed during coronary occlusion to measure risk area and at 100 to 110 min to exclude infarction. MCE molecular imaging was performed at 30 and 90 min after reperfusion using a lipid microbubble bearing dimeric recombinant human P-selectin glycoprotein ligand-1 (MB-YSPSL). Collection of blood for safety data, electrocardiography, and echocardiography were performed at baseline and before and 10 min after each MB-YSPSL injection.


RESULTS
Vital signs, oxygen saturation, electrocardiographic results, ventricular systolic function, pulmonary vascular resistance, and serum safety markers were unchanged by intravenous injection of MB-YSPSL. On echocardiography, left ventricular dysfunction in the risk area had resolved by 30 min, and there was no evidence of infarction on MCE perfusion imaging. On selectin-targeted MCE molecular imaging, signal enhancement was greater (P < .05) in the risk area than remote territory at 30 min (25 ± 11 vs 11 ± 4 IU) and 90 min (13 ± 3 vs 3 ± 2 IU) after ischemia. There was no enhancement (<1 IU) in control nonischemic subjects.


CONCLUSIONS
In primates, MCE molecular imaging of selectins using MB-YSPSL, a recombinant ligand appropriate for humans, is both safe and effective for imaging recent myocardial ischemia. This technique may be useful for detecting recent ischemia in patients with chest pain even in the absence of necrosis.
Knight Cardiovascular Institute, Oregon Health & Science University, Portland, Oregon. Electronic address: davidsbr@ohsu.edu.
Brian P
BP
Davidson
Knight Cardiovascular Institute, Oregon Health & Science University, Portland, Oregon.
Scott M
SM
Chadderdon
Knight Cardiovascular Institute, Oregon Health & Science University, Portland, Oregon.
J Todd
JT
Belcik
Knight Cardiovascular Institute, Oregon Health & Science University, Portland, Oregon.
Saurabh
S
Gupta
Knight Cardiovascular Institute, Oregon Health & Science University, Portland, Oregon.
Jonathan R
JR
Lindner
D000818:Animals; D003331:Coronary Vessels / Q000000981:diagnostic imaging / Q000378:metabolism*; D004195:Disease Models, Animal; D004452:Echocardiography / Q000379:methods*; D008253:Macaca mulatta; D008297:Male; D057054:Molecular Imaging / Q000379:methods*; D017202:Myocardial Ischemia / Q000000981:diagnostic imaging* / Q000378:metabolism; D055414:Myocardial Perfusion Imaging / Q000379:methods*; D009206:Myocardium / Q000378:metabolism*; D019087:Selectins / Q000096:biosynthesis*
D019087:Selectins
Contrast echocardiography; Ischemia; Molecular imaging; Selectins